Implant Sciences Corporation (AMEX: IMX), a high-technology supplier of sophisticated systems and sensors for the homeland security market and related industries, recently discussed the company’s focus on Homeland Security and future expansion plans. Additionally, Implant Sciences announced its first purchase order from the company’s recently awarded General Services Administration (GSA) Schedule Contract.

Implant Sciences has developed proprietary technologies used in its commercial portable and bench-top explosive trace detection systems which ship to a growing number of locations domestically and internationally. The company’s main product line is the Quantum Sniffer, which is available in a portable version (QS-H150) and the bench top variety (QS-B200). The core technology includes the measurement of ions in the air and their time of flight, which give their molecular composition in order to identify the presence of a threat.

Phillip C. Thomas, president and chief executive officer of Implant Sciences, recently stated, “We see substantial new market opportunities in front of us. We’ve seen studies that put the world market for explosives trace detection systems as high as 25 percent compound annual growth rate with a base market more than doubling to over $650 million per year over the next five years.” He commented further stating, “In the past year, we have significantly expanded our servable geographies, introduced a key new product, and made considerable progress on our product roadmap. As a result, we believe the company is well positioned for continued growth.”

Let us hear your thoughts below: